WO2016015055A8 - Colon cleansing compositions - Google Patents
Colon cleansing compositions Download PDFInfo
- Publication number
- WO2016015055A8 WO2016015055A8 PCT/US2015/042298 US2015042298W WO2016015055A8 WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8 US 2015042298 W US2015042298 W US 2015042298W WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colon cleansing
- cleansing compositions
- compositions
- kits
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to compositions comprising guanylate cyclase C agonist peptides, and dosage forms, methods, and kits thereof. The compositions, dosage forms, methods and kits may be used for colon cleansing prior to colonoscopy, or in preparation for other medical, radiologic and/or surgical procedures.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462028963P | 2014-07-25 | 2014-07-25 | |
US62/028,963 | 2014-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016015055A1 WO2016015055A1 (en) | 2016-01-28 |
WO2016015055A8 true WO2016015055A8 (en) | 2016-09-09 |
Family
ID=53777040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/042298 WO2016015055A1 (en) | 2014-07-25 | 2015-07-27 | Colon cleansing compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016015055A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017013928A (en) | 2015-05-01 | 2018-01-15 | Ironwood Pharmaceuticals Inc | Compositions for colon cleansing and the treatment of gastrointestinal disorders. |
RU2713175C1 (en) * | 2019-02-04 | 2020-02-04 | Виктор Анатольевич Маткевич | Acid-mineral composition and enteral solution by matkevich for lavage of gastrointestinal tract and/or correction of homeostasis disorders |
KR20220122613A (en) * | 2019-12-23 | 2022-09-02 | 주식회사 비보존 | colon laxative composition |
CN115040512B (en) * | 2022-07-28 | 2023-06-20 | 苏州中化药品工业有限公司 | Pharmaceutical composition and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140179607A9 (en) * | 2009-11-09 | 2014-06-26 | Ironwood Pharmaceuticals, Inc | Treatments for Gastrointestinal Disorders |
US20160213739A1 (en) * | 2011-05-11 | 2016-07-28 | Ironwood Pharmaceuticals, Inc | Treatments for disorders using guanylate cyclase c agonists |
US9303066B2 (en) * | 2011-05-11 | 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
EP2958577A2 (en) * | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
-
2015
- 2015-07-27 WO PCT/US2015/042298 patent/WO2016015055A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016015055A1 (en) | 2016-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL247659A0 (en) | Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof | |
WO2016100985A3 (en) | Chimeric antigen receptors and methods of use thereof | |
EP3164702A4 (en) | Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance | |
IL273300A (en) | High dosage valbenazine formulation and compositions, methods, and kits related thereto | |
EP3411504A4 (en) | Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes | |
WO2016060996A3 (en) | Interleukin-15 compositions and uses thereof | |
WO2016044463A3 (en) | Mk2 inhibitors and uses thereof | |
WO2014152157A8 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
WO2015171558A3 (en) | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE | |
EP4289820A3 (en) | Compounds for use in treating alzheimer's disease in apoe4+/+ patients | |
SG11201705450SA (en) | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases | |
EP2978423A4 (en) | Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it | |
EP3305802A4 (en) | Novel peptide and composition containing the same | |
WO2016079110A3 (en) | Use of enzyme for cleaning | |
WO2016167944A3 (en) | Compositions and methods for treating autism | |
WO2016020210A8 (en) | Factor viii formulation | |
WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
WO2017011769A3 (en) | Il-17f-specific capture agents, compositions, and methods of using and making | |
EP3497077A4 (en) | Amide compounds, pharmaceutical compositions thereof, and methods of using the same | |
WO2016015055A8 (en) | Colon cleansing compositions | |
WO2015200534A3 (en) | Small molecule agonists of neurotensin receptor 1 | |
EP4342531A3 (en) | Methods of improving myocardial performance in fontan patients using udenafil compositions | |
WO2016094374A8 (en) | Compositions and methods for treatment of friedreich's ataxia | |
EA201691792A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15745741 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15745741 Country of ref document: EP Kind code of ref document: A1 |